Inve India ▾

Clean Science and Technology share price & results

Clean Science and Technology Limited· Chemicals· Commodities

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Pune specialty-chemicals maker; global No.1-2 producer of MEHQ, BHA, TBHQ, HALS via catalytic tech.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue268 ₹ crore+10.3% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin36.0 %−5.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit73.0 ₹ crore+4.3% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity15.46 %−4.8 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin7.84 %+0.4 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)-0.41 %−23.3 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

5 of 11 judged targets kept · 14 open · verdicts reflect calls analysed to Q1 FY27.

Clean Science and Technology Limited management guidance track record on Inve: 25 targets tracked across analysed earnings calls (5 achieved, 6 missed, 14 open).

TargetOriginal wordingSaidLatest callVerdict
HALS Volume2,000 tons in Calendar Year 2025
Call transcript, Q2 FY25 · 7 Nov 2024
Q2 FY25Q1 FY27:No new update. Promise remains achieved.
Call transcript, Q1 FY27 · 1 Aug 2026
Achieved
Pharma Intermediate (DHDT) CommercializationQ3 FY25
Call transcript, Q2 FY25 · 7 Nov 2024
Q2 FY25Q1 FY27:No new update. Promise remains missed as the plant was repurposed.
Call transcript, Q1 FY27 · 1 Aug 2026
Missed
Performance Chemical 2 CommercializationQ4 FY26
Call transcript, Q1 FY26 · 17 Jul 2025
Q1 FY26Q1 FY27:Commercialization further delayed to Q3 FY27 (Nov-Dec '26), a slip from the previous guidance of Sep '26 (Q2 FY27).
Call transcript, Q1 FY27 · 1 Aug 2026
Delayed

Source: Inve Guidance Tracker for Clean Science and Technology Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

6 of Clean Science and Technology Limited's 25 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 22 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹744 +0.92% · +₹6.75

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −29.9% 1Y

₹0.7k₹0.8k₹0.9k₹1.0kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 6 Nov 2025Q3 FY26 — 30 Jan 2026Q4 FY26 — 14 May 2026Q1 FY27 — 31 Jul 2026

1Y: ₹1,061.9 on 24 Oct 2025 → ₹744. High ₹1,061.9 (24 Oct 2025), low ₹656.4 (30 Mar 2026).

Previous close
₹737.25
Market cap
₹7.8k Cr
52-week range
₹656.4 – ₹1,049.5
One year
−28.78%
Price to earnings (TTM to Jun 2026)
33.78×
Return on equity (TTM to Jun 2026)
15.46%

Overview

Symbol
NSE:CLEAN
Sector
Chemicals
Industry
Commodities
Exchange
NSE
Currency
INR

What Clean Science and Technology Limited does

Based on the company's own presentations, annual report and earnings calls.

Clean Science and Technology is a Pune-headquartered fine and specialty chemicals manufacturer that develops proprietary, in-house catalytic manufacturing processes rather than licensing third-party technology. It makes chemical intermediates across three reported segments — Performance Chemicals, Pharma & Agro Intermediates, and FMCG Chemicals — that feed into acrylics/superabsorbent polymers, food and feed preservation, sunscreen and cosmetic actives, and pharmaceutical and agrochemical manufacturing. It holds the largest global manufacturing capacity for several flagship products, including MEHQ, BHA, AP and TBHQ. Manufacturing is concentrated at Kurkumbh Industrial Area, Maharashtra, across three company units plus a fourth HALS-dedicated facility housed in wholly owned subsidiary Clean Fino Chem Ltd.

Segments

  • Performance Chemicals
  • Pharma & Agro Intermediates
  • FMCG Chemicals
Manufacturing units
4 units at Kurkumbh Industrial Area, Maharashtra — Unit 1 (7 plants), Unit 2 (4 plants), Unit 3 (5 plants), plus a dedicated HALS facility (Unit 4) under subsidiary Clean Fino Chem Ltd.
Global market position
Ranked No.1 or No.2 worldwide in MEHQ, BHA, AP, TBHQ, HALS 701, 4-MAP, Anisole and DHDT
Customer base
500+ global and domestic customers across 35+ countries
Product portfolio
11+ named specialty chemicals across 3 operating segments
R&D infrastructure
4 R&D facilities with a pilot plant and application lab; 90+ scientists including 9 PhDs
Workforce
1,500+ employees (~10% women staff)
Headquarters Pune, Maharashtra, India Company website

How the price took the results

close before → close after

Q1 FY27
+4.1%
1 Aug
Q4 FY26
+0.1%
14 May
Q3 FY26
−6.1%
31 Jan
Q2 FY26
−0.3%
6 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Clean Science and Technology Limited

Free account: one company. Everything above stays public.

Write why you follow Clean Science and Technology Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds